Avandia

  1. Actos maker sued over cancer link

    Actos was supposed to be the "safer" alternative to Avandia, the diabetes drug that boosted heart risk so much that it was ultimately pulled from pharmacies.

    In reality, Actos might actually be just as bad for your heart. And even if you manage to survive that risk, you could find yourself in a life-or-death battle with bladder cancer.

    Some alternative!

    Now, Takeda Pharmaceuticals -- the company that makes the drug -- is bracing itself for some 10,000 lawsuits after a study this year found the med can actually increase the risk of bladder cancer by up to 40 percent.

    The news caused France and Germany to pull the drug from the market -- but naturally, the FDA did no such thing. Instead, the agency took just about the weakest action possible: It ordered the company to tweak the fine print on the warning label.

    And that means, as usual, the only one who can protect you is you.

    If you've already made the jump from Avandia to Actos, don't even waste your time looking for your next "safe" landing spot.

    You won't find it.

    Actos, Avandia and the rest of them aren't cures -- they exist only to "manage" the disease, and if you keep taking them you'll manage yourself right into the grave.

    There's just one way to beat diabetes, and that's with the lifestyle changes that would have prevented it in the first place: Give up sugar, give up carbs and get your life back.

    It really is that simple. But if you need a boost, look up benfotiamine. It's a synthetic form of thiamine so powerful it can actually undo years of diabetes damage.

  2. Researchers confirm Avandia risk

    From the department of redundancy department: Researchers say Avandia can up your risk of heart attack, heart failure, and an early death.

    Normally, I wouldn't even waste your time with this. It's hardly news.

    But since some diabetics are actually still taking this med, they need to hear it again -- and maybe this time they'll get the message.

    Researchers crunched the numbers on 810,000 patients who took part in 16 studies, and found that Avandia increased the risk of heart attack by 16 percent, congestive heart failure by 23 percent, and overall mortality by 14 percent.

    That's actually the good news, because other studies have found that those risks can be even higher.

    One study found that Avandia increases the odds of heart attack by up to 39 percent, while another tied it to a 27 percent higher risk of stroke and a 25 percent higher risk of heart failure. (Read more here.)

    But here's the dirty little secret you won't find in those numbers: The real risk may be much, much higher.

    Most studies, including this new one published in BMJ, don't compare Avandia to lifestyle changes, natural supplements or even a placebo.

    They compare it to Actos, a drug that's almost as dangerous... and might even be riskier.

    One study published last year found Actos patients suffered MORE heart attacks than those who took Avandia. That study, published in Circulation: Cardiovascular Quality and Outcomes, also found similar rates of heart failure and the same number of deaths.

    Yet somehow, the mainstream is using the Avandia research as an excuse to move everyone over to Actos.

    Here's a better idea: Don't take either drug.

  3. New rules only apply to new patients

    If you've got one foot in the grave already thanks to Avandia, the feds want to give you a little shove to help finish the job.
  4. New feline study proves I'm not crazy after all

    According to research, anyone who has been exposed to toxoplasma - which, potentially, might mean anyone who has pet cats - could have a greater chance of developing schizophrenia.

4 Item(s)